Cancer researchers find up to one-quarter of lung cancer patients may be ineligible for immunotherapy

Cancer researchers Dr. Saad Khan, Dr. Sandi Pruitt, Dr. David Gerber, and Dr. Lei Xuan
UT Southwestern cancer researchers Dr. Saad Khan, Dr. Sandi Pruitt, Dr. David Gerber, and Dr. Lei Xuan found that a significant proportion of lung cancer patients also have autoimmune disease.

A significant proportion of lung cancer patients also have autoimmune disease, which may make them unsuitable for increasingly popular immunotherapy treatments, a team of researchers at UT Southwestern Medical Center’s Harold C. Simmons Comprehensive Cancer Center has found. Read the full article at UT Southwestern's News archives.